875-P: Baseline Characteristics for FINE-ONE—A Randomized Phase III Trial Assessing Finerenone in People with T1D and CKDHiddo J.L. Heerspink, Andreas L. Birkenfeld, Linong Ji et al.|Diabetes|2025Cited by 0